- What is Qualigen Therapeutics, Inc.'s stock symbol?
Our stock is traded on the Nasdaq under the symbol QLGN.
- When was Qualigen Therapeutics, Inc. incorporated?
Qualigen, Inc. was originally incorporated in Minnesota as a privately held corporation in 1996. Qualigen Therapeutics, Inc. (formerly Ritter Pharmaceuticals, Inc.) was formed as a Nevada limited liability company on March 29, 2004 under the name Ritter Natural Sciences, LLC. In September 2008, the company was converted into a Delaware corporation under the name Ritter Pharmaceuticals, Inc. In May 2020, Ritter Pharmaceuticals, Inc. entered into a reverse merger transaction with Qualigen, Inc. pursuant to which Qualigen, Inc. became a wholly-owned subsidiary of Ritter Pharmaceuticals, Inc. Following the reverse merger transaction, Ritter Pharmaceuticals, Inc. changed its name to Qualigen Therapeutics, Inc
- When did Qualigen Therapeutics, Inc. become a public company?
June 29, 2015 as Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR). Renamed Qualigen Therapeutics, Inc. on May 22, 2020 (Nasdaq: QLGN).
- Where is Qualigen Therapeutics, Inc. located?
2042 Corte del Nogal
Suite B
Carlsbad, CA 92011- When is Qualigen Therapeutics, Inc.'s fiscal year end?
December 31st
- Who is Qualigen Therapeutics, Inc.'s transfer agent?
EQ Shareowner Services
PO Box 64874
St Paul MN 55164
T: 800-468-9716
ShareownerOnline.com- Who is Qualigen Therapeutics, Inc.'s independent auditor?
Baker Tilly US, LLP
- Who is Qualigen Therapeutics, Inc.'s outside legal counsel?
Stradling Yocca Carlson & Rauth, P.C.
www.sycr.com